Get Smart: REITs for the Long Term
It's not been an easy ride for REITs over the past five years.
First, there was the pandemic in 2020 which forced malls and offices to impose movement control measures.
Then, just as things were looking up in 2022, the sector was hit with higher interest rates.
Amid all the challenges, it's easy to forget a simple fact: REITs are built to provide income to unitholders like you and me.
And when things get messy, it's useful to return to the core principles.
REITs are bundles of rental-generation real estate assets that are packaged together and traded on an exchange.
Their requirement to pay out a distribution that is at least 90% of their net profit makes them ideal for income-seeking investors.
If you wish to rely on a steady stream of dividends that help you to augment your earned income, REITs are the perfect asset class for you.
You can treat it as a long-term bond-like instrument that distributes regular income from a recurring rental income stream.
It's easy to forget this simple fact amid the noise.
But one thing's for sure – all of them are continuing to pay out distributions to their unitholders.
At a recent event, my colleague Chin was one of the speakers invited to share his thoughts.
He made three very good points about buying REITs that I am happy to share with all of you.
Because we cannot control the external environment, we should, instead, stick to what we can control.
And we can control which REITs we buy, how much of them we purchase, and when we buy them.
The idea is to scan through the list of available REITs on the Singapore Exchange and pick those with strong sponsors and solid DPU track records.
Strong sponsors include CapitaLand Investment Limited (SGX: 9CI) and Mapletree Investments Pte Ltd.
A great example of a REIT with a solid DPU track record is Parkway Life REIT (SGX: C2PU), which has grown its core DPU every year since its IPO in 2007.
Next, you can control your risk by sizing your position accordingly.
If you feel comfortable with a REIT such as Mapletree Industrial Trust (SGX: ME8U), it can occupy a 5% position within your portfolio.
But if you feel wary of it, but still wish to gain some exposure, you can buy either a 0.5% or 1% position.
Finally, you can also choose when to buy your REITs so that you space out your purchases.
You can choose to set up a system of regular purchases by allocating several hundred dollars a month to buy a choice REIT.
Or to wait for a sharp market pullback to increase your stake in REITs that you favour.
It's really up to you.
The key is to remember that REITs are meant for income, and if you buy enough of the right REIT, then you can secure a useful stream of passive income for life.
REITs are at a crossroads now.
Singapore REITs are trading at almost a 20% discount to their long-term average valuation.
This fact implies that they are cheap because of the poor sentiment surrounding the asset class.
But with patience and the right selection, it may be a great opportunity to scoop up REITs for the long term.
By doing so, you can enjoy average distribution yields of around 6% to 7% and increase your passive income stream for life.
This could be the fastest way to jump from a 'newbie' investor to a seasoned pro. Our beginner's guide shows everything you need to know to buy your first stock and beyond. Click here to download it for free today.
Follow us on Facebook and Telegram for the latest investing news and analyses!
Disclosure: Royston Yang owns shares of Mapletree Industrial Trust.
The post Get Smart: REITs for the Long Term appeared first on The Smart Investor.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Frencken Group Limited's (SGX:E28) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Frencken Group's (SGX:E28) stock is up by a considerable 14% over the past month. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. In this article, we decided to focus on Frencken Group's ROE. Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. The formula for ROE is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Frencken Group is: 8.4% = S$37m ÷ S$438m (Based on the trailing twelve months to December 2024). The 'return' is the income the business earned over the last year. That means that for every SGD1 worth of shareholders' equity, the company generated SGD0.08 in profit. See our latest analysis for Frencken Group Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features. When you first look at it, Frencken Group's ROE doesn't look that attractive. Although a closer study shows that the company's ROE is higher than the industry average of 3.9% which we definitely can't overlook. However, Frencken Group's five year net income decline rate was 4.9%. Bear in mind, the company does have a slightly low ROE. It is just that the industry ROE is lower. So that could be one of the factors that are causing earnings growth to shrink. So, as a next step, we compared Frencken Group's performance against the industry and were disappointed to discover that while the company has been shrinking its earnings, the industry has been growing its earnings at a rate of 9.8% over the last few years. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Frencken Group's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry. Looking at its three-year median payout ratio of 30% (or a retention ratio of 70%) which is pretty normal, Frencken Group's declining earnings is rather baffling as one would expect to see a fair bit of growth when a company is retaining a good portion of its profits. So there could be some other explanations in that regard. For instance, the company's business may be deteriorating. Additionally, Frencken Group has paid dividends over a period of at least ten years, which means that the company's management is determined to pay dividends even if it means little to no earnings growth. Upon studying the latest analysts' consensus data, we found that the company is expected to keep paying out approximately 32% of its profits over the next three years. Therefore, the company's future ROE is also not expected to change by much with analysts predicting an ROE of 9.8%. In total, it does look like Frencken Group has some positive aspects to its business. However, while the company does have a decent ROE and a high profit retention, its earnings growth number is quite disappointing. This suggests that there might be some external threat to the business, that's hampering growth. With that said, we studied the latest analyst forecasts and found that while the company has shrunk its earnings in the past, analysts expect its earnings to grow in the future. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
All Charges Dismissed Against Dr. Kingsley R. Chin and His Companies as DOJ Case Concludes
After a multi-year DOJ investigation, all criminal charges against Dr. Kingsley R. Chin and his medical device company, SpineFrontier, have been dismissed, allowing him to focus on transforming spine care and improving patient outcomes. FORT LAUDERDALE, Fla., May 30, 2025 /PRNewswire/ -- All criminal charges have been dismissed against Dr. Kingsley R. Chin and his medical device companies, bringing an end to a multi-year investigation by the U.S. Department of Justice (DOJ). The case began in 2016 after three former employees, acting as whistleblowers under the False Claims Act, triggered a civil inquiry into Dr. Chin and SpineFrontier , the company he founded and led as CEO since 2006. That civil matter was fully resolved in November 2023. In 2021, the DOJ initiated a separate criminal investigation. In early 2025, charges against SpineFrontier were formally dismissed. By May 2025, the DOJ moved to dismiss all remaining charges against Dr. Chin. "All of the charges in the Indictment and Superseding Indictment against Dr. Chin have been or are going to be dismissed, as the case resolved for a lesser charge," stated Dr. Chin's legal counsel in a recent interview. Dr. Chin is a Harvard-trained professor and board-certified orthopedic spine surgeon and a graduate of Harvard Business School. He is widely recognized for pioneering Less Exposure Spine Surgery (LESS™), a philosophy that advances outpatient spine care and empowers physician-led medical innovation. With this legal chapter now coming to a close, Dr. Chin remains focused on transforming spine care and improving patient outcomes through continued innovation and leadership in the medical technology field. About SpineFrontier in 2006, SpineFrontier was built on a foundation of collaboration and innovation. Along with its strategic advisory board of spine surgeons, the company developed a portfolio of Less Exposure Spine Surgery (LESS) technologies designed to improve patient outcomes and simplify procedures for outpatient spine surgery. About KIC in 2013 as the venture arm of Kingsley Investment Company (KIC) LLC, KIC Ventures focuses exclusively on advancing outpatient spine surgery through its Less Exposure Spine Surgery (LESS™) philosophy. With a portfolio of innovative spine technologies and a commitment to empowering physicians, KIC Ventures has become the world's largest private equity firm with a majority-owned portfolio of differentiated spine companies focused on outpatient spine solutions. View original content to download multimedia: SOURCE KIC Ventures Sign in to access your portfolio
Yahoo
7 hours ago
- Yahoo
Bullish: Analysts Just Made An Upgrade To Their Yanlord Land Group Limited (SGX:Z25) Forecasts
Celebrations may be in order for Yanlord Land Group Limited (SGX:Z25) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Following the upgrade, the consensus from twin analysts covering Yanlord Land Group is for revenues of CN¥31b in 2025, implying a definite 16% decline in sales compared to the last 12 months. The losses are expected to disappear over the next year or so, with forecasts for a profit of CN¥0.011 per share this year. Yet prior to the latest estimates, the analysts had been forecasting revenues of CN¥22b and losses of CN¥0.46 per share in 2025. So we can see that this has sparked a pretty clear upgrade to expectations, with higher revenues anticipated to lead to profit sooner than previously forecast. Check out our latest analysis for Yanlord Land Group Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that sales are expected to reverse, with a forecast 16% annualised revenue decline to the end of 2025. That is a notable change from historical growth of 15% over the last five years. Yet aggregate analyst estimates for other companies in the industry suggest that industry revenues are forecast to decline 1.7% per year. The forecasts do look bearish for Yanlord Land Group, since they're expecting it to shrink faster than the industry. The most important thing to take away from this upgrade is that there is now an expectation for Yanlord Land Group to become profitable this year, compared to previous expectations of a loss. They also upgraded their revenue estimates, with sales apparently performing well even though revenue growth expected to decline against the wider market this year. More bullish expectations could be a signal for investors to take a closer look at Yanlord Land Group. Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. We have analyst estimates for Yanlord Land Group going out as far as 2026, and you can see them free on our platform here. Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are upgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
